Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice

被引:12
|
作者
Wu, Hongyan [1 ,2 ]
Yang, Jing [1 ,2 ]
Liu, Yun-Qiang [3 ]
Lei, Song [4 ]
Yang, Mei [4 ]
Yang, Zhi [1 ,2 ]
Yang, Yuan [3 ]
Hu, Zhangxue [1 ,2 ]
机构
[1] Sichuan Univ, Dept Nephrol, West China Hosp, Guoxue Alley,37, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, Natl Clin Res Ctr Geriatr, West China Hosp, Guoxue Alley,37, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, Dept Med Genet, West China Hosp, Chengdu, Peoples R China
[4] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
Lipoprotein glomerulopathy; ApoE Kyoto (p; R43C); ApoE Sendai (p; R163P); Atherosclerosis; Recombinant adenovirus;
D O I
10.1186/s12967-021-02765-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant kidney disease that is most commonly caused by mutations in ApoE Kyoto (p.R43C) and ApoE Sendai (p.R163P). Differences in phenotype among the various ApoE mutations have been suggested, but the pathogenic role of ApoE Kyoto has not been validated in an animal model. This study intended to establish an ApoE Kyoto murine model and to further compare the pathologic differences between ApoE Kyoto and ApoE Sendai. Method Male ApoE-deficient mice, 3 months of age, were divided into five groups, including the AD-ApoE Sendai, AD-ApoE Kyoto, AD-ApoE3, AD-eGFP, and ApoE (-/-) groups. The first four groups received recombinant adenovirus that contained the entire coding regions of the human ApoE Sendai and ApoE Kyoto, apoE3, and eGFP genes, respectively. Fasting blood and urine samples were collected at multiple time points. Lipid profiles and urine albumin-creatinine ratio were measured. Renal and aortic histopathologic alterations were analyzed. Results After virus injection, plasma human ApoE was detected and rapidly reached the maximum level at 4-6 days in the AD-ApoE Kyoto and AD-ApoE Sendai groups (17.4 +/- 3.1 mu g/mL vs.: 22.2 +/- 4.5 mu g/mL, respectively) and at 2 days in the AD-ApoE3 group (38.4 mu g/mL). The serum total cholesterol decreased by 63%, 65%, and 73% in the AD-ApoE Kyoto, AD-ApoE Sendai and AD-ApoE3 groups, respectively. There were no significant changes in serum triglyceride and urinary albumin-creatinine ratio among the five groups. Typical lipoprotein thrombi with positive ApoE staining were detected in the AD-ApoE Kyoto and AD-ApoE Sendai groups. The Oil-red O-positive glomerular area tended to be higher in the AD-ApoE Kyoto group (9.2%) than in the AD-ApoE Sendai (3.9%), AD-ApoE3 (4.8%), AD-eGFP (2.9%), and ApoE (-/-) (3.6%) groups. The atherosclerotic plaque area in the aorta was lower in the group injected with various ApoE mutations than in the group without injection of ApoE mutation. Conclusions In this animal study, we first established an ApoE Kyoto mutation murine model and confirmed its pathogenic role in LPG. Our results suggested that LPG may be more severe with the ApoE Kyoto than with the ApoE Sendai.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy
    Kentaro Toyota
    Taeko Hashimoto
    Daisuke Ogino
    Akira Matsunaga
    Minoru Ito
    Ikuto Masakane
    Noriyuki Degawa
    Hiroshi Sato
    Sayuri Shirai
    Kazuo Umetsu
    Gen Tamiya
    Takao Saito
    Kiyoshi Hayasaka
    Journal of Human Genetics, 2013, 58 : 254 - 258
  • [42] Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice
    Chiba, Tsuyoshi
    Shinozaki, Shohei
    Nakazawa, Toru
    Kawakami, Akio
    Ai, Masumi
    Kaneko, Eiji
    Kitagawa, Masanobu
    Kondo, Kazuo
    Chait, Alan
    Shimokado, Kentaro
    ATHEROSCLEROSIS, 2008, 196 (01) : 68 - 75
  • [43] Mechanism of microRNA regulating the progress of atherosclerosis in apoE-deficient mice
    Lou, Xiaoqian
    Wang, Dawei
    Gu, Zehui
    Li, Tengteng
    Ren, Liqun
    BIOENGINEERED, 2021, 12 (02) : 10994 - 11006
  • [44] The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice
    Lee, TS
    Yen, HC
    Pan, CC
    Chau, LY
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) : 734 - 742
  • [45] Protective effects of ramalin against atherosclerosis in ApoE-deficient mice
    Park, Hye-Jin
    Byeon, Hye-Eun
    Koo, Hyun-Jung
    Yim, Joung Han
    Lee, Hong Kum
    Pyo, Suhkneung
    FASEB JOURNAL, 2011, 25
  • [46] Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice
    Caligiuri, G
    Nicoletti, A
    Zhou, XH
    Törnberg, I
    Hansson, GK
    ATHEROSCLEROSIS, 1999, 145 (02) : 301 - 308
  • [47] Anti-atherosclerotic effects of diosgenin in ApoE-deficient mice
    Park, Hye-Jin
    Byeon, Hye-Eun
    Koo, Hyun-Jung
    Pyo, Suhkneung
    FASEB JOURNAL, 2011, 25
  • [48] Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice
    Zhou, J
    Moller, J
    Ritskes-Hoitinga, M
    Larsen, ML
    Austin, RC
    Falk, E
    ATHEROSCLEROSIS, 2003, 168 (02) : 255 - 262
  • [49] Role of CaMKII in Atherosclerotic Plaque Progression in ApoE-Deficient Mice
    Ebenebe, Obialunanma V.
    Heather, Alison K.
    Erickson, Jeffrey R.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [50] NEURODEGENERATION IN THE CENTRAL-NERVOUS-SYSTEM OF APOE-DEFICIENT MICE
    MASLIAH, E
    MALLORY, M
    GE, NF
    ALFORD, M
    VEINBERGS, I
    ROSES, AD
    EXPERIMENTAL NEUROLOGY, 1995, 136 (02) : 107 - 122